LARIMAR THERAPEUTICS INC (LRMR) Stock Analyst Earnings Estimates
NASDAQ:LRMR - Nasdaq - US5171251003 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 436.48% | N/A 160.33% | N/A 98.97% | N/A 66.46% | N/A 9.44% | N/A -29.90% | |||||||||||
| EBITDA YoY % growth | -35.51M | -73.74M -107.66% | -58.02M 21.32% | -52.81M 8.98% | -60.86M -15.24% | -39.84M 34.54% | -42.64M -7.03% | -50.14M -17.59% | -36.21M 27.78% | -41.447M -14.46% | N/A -92.13% | N/A -31.00% | N/A -31.36% | N/A 21.47% | N/A 161.90% | N/A 573.78% | N/A 73.05% | N/A 25.63% | N/A | |
| EBIT YoY % growth | -35.53M | -73.81M -107.74% | -58.23M 21.11% | -53M 8.98% | -61.12M -15.32% | -40.1M 34.39% | -42.8M -6.73% | -50.47M -17.92% | -36.53M 27.62% | -41.758M -14.31% | N/A -100.20% | N/A -40.79% | N/A -32.83% | N/A 40.45% | N/A 150.51% | N/A 772.67% | N/A 124.03% | N/A 5.11% | N/A | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -33.24 13.70% | -25.44 23.47% | -22.92 9.91% | -23.40 -2.09% | -13.20 43.59% | -3.94 70.15% | -2.97 24.62% | -1.54 48.15% | -0.85 44.81% | N/A -45.96% | N/A -30.30% | N/A -30.70% | N/A 37.96% | N/A 81.84% | N/A 569.35% | N/A 334.25% | N/A -89.70% | N/A 83.67% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.31 -4.86% | -0.34 -24.14% | -0.37 -9.74% | -0.42 -73.23% | -0.44 -39.83% | -0.44 -30.86% | -0.44 -17.55% | -0.44 -5.50% | -0.45 -2.03% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | -22.4M -61.72% | -23.059M -38.46% | -25.15M -2.94% | -26.856M -49.01% | -26.213M -17.02% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -22.75M -60.64% | -24.665M -47.40% | -27.496M -11.78% | -30.389M -66.39% | -34.473M -51.53% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.24 -14.29% | -0.38 | 0.14 | 37.25% |
| Q2 2024 Q2Q % growth | -0.34 -78.95% | -0.31 | -0.03 | -9.17% |
| Q1 2024 Q2Q % growth | -0.27 -80.00% | -0.24 | -0.03 | -12.64% |
| Q4 2023 Q2Q % growth | -0.30 -42.86% | -0.25 | -0.05 | -18.88% |
| Q3 2023 Q2Q % growth | -0.21 43.24% | -0.23 | 0.02 | 7.84% |
| Q2 2023 Q2Q % growth | -0.19 59.57% | -0.20 | 0.01 | 4.47% |
| Q1 2023 Q2Q % growth | -0.15 69.39% | -0.25 | 0.10 | 40.22% |
| Q4 2022 Q2Q % growth | -0.21 58.00% | -0.28 | 0.07 | 24.45% |
| Q3 2022 Q2Q % growth | -0.37 59.78% | -0.43 | 0.06 | 13.63% |
| Q2 2022 Q2Q % growth | -0.47 40.51% | -0.58 | 0.11 | 19.63% |
| Q1 2022 Q2Q % growth | -0.49 35.53% | -0.52 | 0.03 | 5.81% |
| Q4 2021 Q2Q % growth | -0.50 43.82% | -0.73 | 0.23 | 31.60% |
| Q3 2021 Q2Q % growth | -0.92 -43.75% | -0.66 | -0.26 | -40.20% |
| Q2 2021 Q2Q % growth | -0.79 34.71% | -0.76 | -0.03 | -3.73% |
| Q1 2021 Q2Q % growth | -0.76 36.67% | -0.88 | 0.12 | 13.86% |
| Q4 2020 Q2Q % growth | -0.89 60.96% | -0.71 | -0.18 | -24.65% |
| Q3 2020 Q2Q % growth | -0.64 77.78% | % | ||
| Q2 2020 Q2Q % growth | -1.21 68.49% | % | ||
| Q1 2020 Q2Q % growth | -1.20 71.43% | % | ||
| Q4 2019 Q2Q % growth | -2.28 | -2.33 | 0.05 | 1.96% |
| Q3 2019 Q2Q % growth | -2.88 | -3.26 | 0.38 | 11.77% |
| Q2 2019 Q2Q % growth | -3.84 | -4.47 | 0.63 | 14.05% |
| Q1 2019 Q2Q % growth | -4.20 | -5.19 | 0.99 | 19.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 18.52% | 0% | 13.89% |
| Revenue | N/A | N/A | N/A | N/A |